IBC Generium Chooses Partner to Develop IgG-based Antibody as Possible Lymphoma Treatment
News
IBC Generium (also known as International Biotechnology Center Generium) has selected Goodwin Biotechnology to access, process and manufacture its immunoglobulin G (IgG)-based, bispecific antibody, GNR-047, to prepare it for testing in early clinical trials it plans to conduct in ... Read more